Frontage Laboratories, Inc · 4 hours ago
Research Technician I
Chicago, IL, US
Full-time
Onsite
New Grad, Entry Level
$24/hr - $28/hr
0+ years expFrontage Laboratories Inc. is an award-winning, full-service CRO operating over 25 laboratories. The Research Technician plays a key role in conducting preclinical studies and supports the Study Director to ensure studies are conducted according to FDA guidelines.
BiotechnologyClinical TrialsMedicalPharmaceuticalRobotics
Responsibilities
Duties include handling, dosing, bleeding, weighing, and observing animals
Recording and summarizing data
Other responsibilities as assigned
Qualification
Required
Candidates must have a BS degree in animal/veterinary science, biology, or related disciplines
The Research Technician I position requires 0-3 years of experience
Preferred
Knowledge of Good Laboratory Practice (GLP) Regulations as well as past experience in the conduct of toxicology studies or animal handling is a plus
AALAS accreditation is a plus
Benefits
401k Employer Match with immediate vesting
Medical Insurance
High Deductible/HSA
Low PPO
High PPO
Dental Insurance
Low PPO
High PPO
Vision Insurance
FSA (Medical, Dependent Care, and Commuter)
Short Term Disability
Long Term Disability
Life Insurance
Generous PTO
Company
Frontage Laboratories, Inc
Frontage Laboratories is a US-based Contract Research Organization (CRO) that was initially established in New Jersey in April 2001 and later relocated to Pennsylvania in 2004.
1001-5000 employees
H1B Sponsorship
Frontage Laboratories, Inc has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (38)
2024 (37)
2023 (24)
2022 (29)
2021 (34)
2020 (45)
Funding
Current Stage
Public CompanyTotal Funding
$42.37MKey Investors
Baird Capital
2019-05-30IPO
2018-03-01Undisclosed· $32.37M
2014-05-08Acquired
Leadership Team
Song Li
CEO
Abdul Mutlib
Vice President
Recent News
Company data provided by crunchbase